V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001724 | 230009195 | 1.69 | 71 | Adjuvant (A) | 2020-11-17 | 2020-12-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100587386 |
| 230001732 | 230009198 | 1.68 | 74 | null | 2016-08-30 | 2017-04-06 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101640570 |
| 230001733 | 230009199 | 1.62 | 89 | null | 2019-04-15 | 2019-04-15 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100913514 |
| 230001734 | 230009200 | null | null | null | null | 2021-03-17 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100722563 |
| 230001737 | 230009201 | 1.67 | 56.7 | Palliative (P) | null | 2020-03-18 | null | null | N | HYDROXYCARBAMIDE | 101092550 |
| 230001739 | 230009202 | 1.69 | 48.4 | null | null | 2021-09-05 | Niraparib | 02 | null | NIRAPARIB | 100856639 |
| 230001744 | 230009204 | null | null | Palliative (P) | 2019-10-27 | 2019-12-09 | Niraparib | 02 | null | NIRAPARIB | 101050572 |
| 230001745 | 230009205 | 1.54 | null | null | 2022-03-25 | 2022-04-13 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101315132 |
| 230001747 | 230009206 | 1.47 | 63.7 | Palliative (P) | 2017-08-27 | 2019-08-05 | null | null | N | BEVACIZUMAB | 100310453 |
| 230001749 | 230009207 | null | null | Palliative (P) | 2020-09-20 | 2020-10-18 | null | null | N | CARBOPLATIN + GEMCITABINE | 100466822 |
| 230001751 | 230009208 | 1.63 | 76.3 | null | 2019-12-30 | 2019-12-30 | null | 02 | null | PEMBROLIZUMAB | 101665032 |
| 230001765 | 230009211 | null | null | null | 2021-03-05 | 2021-03-12 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101085764 |
| 230001767 | 230009212 | null | null | Palliative (P) | 2019-06-20 | 2019-06-20 | ICON8B TRIAL | null | N | PACLITAXEL | 101124721 |
| 230001771 | 230009215 | 1.7 | 50.9 | null | null | 2021-12-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100089025 |
| 230001774 | 230009216 | null | null | Palliative (P) | 2021-02-13 | 2021-02-13 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101164593 |
| 230001781 | 230009218 | 1.59 | 60.3 | Neo-adjuvant (N) | 2016-07-06 | 2019-03-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101484582 |
| 230001786 | 230009219 | 1.49 | 51.2 | Adjuvant (A) | 2017-02-18 | 2017-08-01 | Bevacizumab | 02 | N | BEVACIZUMAB | 101843485 |
| 230001787 | 230009220 | 1.66 | 61.9 | null | 2020-01-17 | 2020-01-20 | PEMBROLIZUMAB | 02 | null | TRIAL UNSPECIFIED | 101286448 |
| 230001797 | 230009223 | 1.57 | 57 | Neo-adjuvant (N) | 2019-05-09 | 2019-08-01 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100611585 |
| 230001798 | 230009224 | 1.66 | 55.4 | Neo-adjuvant (N) | null | 2019-08-08 | null | null | N | ATTEND TRIAL | 101110498 |
| 230001803 | 230009226 | 1.68 | 96.2 | Palliative (P) | 2018-11-21 | 2018-12-13 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101136294 |
| 230001808 | 230009227 | 1.61 | 126.7 | null | 2021-03-27 | 2021-04-02 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100134614 |
| 230001810 | 230009229 | 1.61 | 42.8 | 03 | 2018-08-08 | 2018-08-22 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101108378 |
| 230001812 | 230009230 | 1.59 | 62.2 | Palliative (P) | 2019-03-10 | 2020-02-22 | CYCLOPHOSPHAMIDE | 02 | null | TRASTUZUMAB | 101686049 |
| 230001815 | 230009231 | 1.53 | 101 | null | 2020-10-30 | 2020-10-30 | Niraparib | 02 | null | NIRAPARIB | 101779065 |
| 230001817 | 230009232 | 1.62 | 71.8 | Adjuvant (A) | null | 2021-03-10 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100834006 |
| 230001818 | 230009233 | null | null | Palliative (P) | null | 2019-11-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101084133 |
| 230001821 | 230009235 | 1.78 | 94.6 | null | 2021-06-21 | 2021-06-24 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100202515 |
| 230001822 | 230009236 | 1.65 | 82.4 | null | 2019-05-25 | 2019-06-09 | ETOPOSIDE | 02 | null | TRIAL UNSPECIFIED | 101218559 |
| 230001825 | 230009237 | 1.65 | 73 | null | 2021-09-27 | 2022-04-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101658344 |
| 230001828 | 230009238 | null | null | null | 2021-01-09 | 2021-03-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100446663 |
| 230001835 | 230009240 | 1.58 | 63.7 | null | 2021-01-27 | 2021-03-15 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101058651 |
| 230001840 | 230009242 | 1.63 | 128 | null | null | 2021-02-28 | Dacarbazine | 02 | null | CISPLATIN + ETOPOSIDE | 100630875 |
| 230001844 | 230009244 | 1.59 | 71.3 | null | 2020-05-02 | 2020-11-17 | PACLITAXEL | 02 | null | PACLITAXEL | 101500385 |
| 230001848 | 230009245 | null | null | null | null | 2021-08-26 | ICON8B TRIAL | 02 | null | PEMBROLIZUMAB | 101558616 |
| 230001850 | 230009246 | 1.74 | 61.8 | Palliative (P) | 2018-08-13 | 2019-01-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100891161 |
| 230001851 | 230009247 | null | null | null | null | 2022-05-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101144977 |
| 230001857 | 230009248 | 1.61 | 72.4 | null | null | 2021-01-16 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100311486 |
| 230001865 | 230009250 | null | null | null | null | 2017-11-20 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101083578 |
| 230001866 | 230009251 | 1.57 | 49.3 | null | null | 2021-05-22 | Olaparib | 02 | null | OLAPARIB | 100122229 |
| 230001869 | 230009252 | 1.7 | 103.3 | null | 2019-07-16 | 2020-01-07 | Rucaparib | 02 | null | RUCAPARIB | 100535021 |
| 230001870 | 230009253 | 1.52 | 74.5 | null | 2022-04-16 | 2022-04-18 | NIVOLUMAB | N | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101857326 |
| 230001875 | 230009255 | 1.59 | 74 | null | null | 2021-02-23 | null | 02 | null | CISPLATIN | 100606077 |
| 230001880 | 230009258 | 1.65 | 83 | Curative (C) | null | 2020-09-19 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101351228 |
| 230001886 | 230009260 | 1.65 | 53.8 | Palliative (P) | 2018-03-11 | 2018-03-26 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100798503 |
| 230001898 | 230009263 | null | null | null | 2015-03-04 | 2016-06-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101715764 |
| 230001901 | 230009264 | null | null | null | null | 2022-04-06 | Cisplatin + Radiotherapy | N | null | CARBOPLATIN | 101360949 |
| 230001903 | 230009265 | 1.65 | 67.5 | null | 2019-03-22 | 2020-09-14 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100289576 |
| 230001907 | 230009267 | 1.55 | 66.4 | null | 2020-08-20 | 2020-08-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101050409 |
| 230001915 | 230009270 | null | null | null | null | 2020-04-18 | PACLITAXEL | 02 | null | PACLITAXEL | 100824041 |